BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11119053)

  • 1. [Lysosome enzyme pseudodeficiency].
    Bronner P; Rodier G; Cohen E; Derouiche F; Boulay C; Courtois S
    Rev Neurol (Paris); 2000 Nov; 156(11):1005-12. PubMed ID: 11119053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pseudodeficiency of lysosomal enzymes].
    Czartoryska B
    Neurol Neurochir Pol; 1995; 29(1):7-15. PubMed ID: 7596481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of frequencies of alleles, associated with the pseudodeficiency of lysosomal hydrolases, in population of Ukraine.
    Olkhovych NV; Gorovenko NG
    Ukr Biochem J; 2016; 88(5):96-106. PubMed ID: 29235819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal storage disorders.
    Sheth J; Patel P; Sheth F; Shah R
    Indian Pediatr; 2004 Mar; 41(3):260-5. PubMed ID: 15064514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metachromatic leukodystrophy: multiple nonfunctional and pseudodeficiency alleles in a pedigree: problems with diagnosis and counseling.
    Francis GS; Bonni A; Shen N; Hechtman P; Yamut B; Carpenter S; Karpati G; Chang PL
    Ann Neurol; 1993 Aug; 34(2):212-8. PubMed ID: 8101704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of lysosomal hydrolases in apparently healthy individuals.
    Zlotogora J; Bach G
    Am J Med Genet; 1983 Jan; 14(1):73-80. PubMed ID: 6131608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of arylsulfatase A mutations located on the same allele to enzyme activity reduction and metachromatic leukodystrophy severity.
    Regis S; Corsolini F; Stroppiano M; Cusano R; Filocamo M
    Hum Genet; 2002 Apr; 110(4):351-5. PubMed ID: 11941485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arylsulfatase A pseudodeficiency incidence in Turkey.
    Emre S; Topçu M; Terzioğlu M; Renda Y
    Turk J Pediatr; 2000; 42(2):115-7. PubMed ID: 10936976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening patients referred to a metabolic clinic for lysosomal storage disorders.
    Fuller M; Tucker JN; Lang DL; Dean CJ; Fietz MJ; Meikle PJ; Hopwood JJ
    J Med Genet; 2011 Jun; 48(6):422-5. PubMed ID: 21415080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening for lysosomal storage disorders.
    Meikle PJ; Grasby DJ; Dean CJ; Lang DL; Bockmann M; Whittle AM; Fietz MJ; Simonsen H; Fuller M; Brooks DA; Hopwood JJ
    Mol Genet Metab; 2006 Aug; 88(4):307-14. PubMed ID: 16600651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations in the arylsulfatase A gene in eight Italian families with metachromatic leukodystrophy.
    Bertelli M; Gallo S; Buda A; Cecchin S; Fabbri A; Lapucci C; Andrighetto G; Sidoti V; Lorusso L; Pandolfo M
    J Clin Neurosci; 2006 May; 13(4):443-8. PubMed ID: 16678723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic errors and enzyme replacement strategies.
    Brady RO
    Res Publ Assoc Res Nerv Ment Dis; 1983; 60():181-93. PubMed ID: 6130585
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical clinical course in juvenile metachromatic leukodystrophy involving novel arylsulfatase A gene mutations.
    Anlar B; Waye JS; Eng B; Oguz KK
    Dev Med Child Neurol; 2006 May; 48(5):383-7. PubMed ID: 16608548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte sonicates as a source for both enzyme assay and DNA amplification for mutational analysis of certain lysosomal disorders.
    Louie E; Rafi MA; Wenger DA
    Clin Chim Acta; 1991 May; 199(1):7-15. PubMed ID: 1682071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrafamilial variability in lysosomal storage diseases.
    Zlotogora J
    Am J Med Genet; 1987 Jul; 27(3):633-8. PubMed ID: 3115101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of acid ceramidase deficiency in patients with Farber disease.
    Bär J; Linke T; Ferlinz K; Neumann U; Schuchman EH; Sandhoff K
    Hum Mutat; 2001 Mar; 17(3):199-209. PubMed ID: 11241842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tay-Sachs disease (beta-hexosaminidase alpha-chain deficiency)].
    Okada S; Taniike M
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):394-6. PubMed ID: 9645090
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease.
    Leinekugel P; Michel S; Conzelmann E; Sandhoff K
    Hum Genet; 1992 Mar; 88(5):513-23. PubMed ID: 1348043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel pseudodeficiency allele in the GLB1 gene in a carrier of GM1 gangliosidosis.
    Gort L; Santamaria R; Grinberg D; Vilageliu L; Chabás A
    Clin Genet; 2007 Aug; 72(2):109-11. PubMed ID: 17661814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve different enzyme assays on dried-blood filter paper samples for detection of patients with selected inherited lysosomal storage diseases.
    Civallero G; Michelin K; de Mari J; Viapiana M; Burin M; Coelho JC; Giugliani R
    Clin Chim Acta; 2006 Oct; 372(1-2):98-102. PubMed ID: 16712827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.